APA (7th ed.) Citation

A, C., L, D., A, F., A, T., C, C., M, B., . . . B, T. (2025). Immune checkpoint inhibitors-induced large vessel vasculitis: Clinical characteristics and management from a European multicentre study. Rheumatology (Oxford, England), 64(8), 4546. https://doi.org/10.1093/rheumatology/keaf172

Chicago Style (17th ed.) Citation

A, Cottu, et al. "Immune Checkpoint Inhibitors-induced Large Vessel Vasculitis: Clinical Characteristics and Management from a European Multicentre Study." Rheumatology (Oxford, England) 64, no. 8 (2025): 4546. https://doi.org/10.1093/rheumatology/keaf172.

MLA (9th ed.) Citation

A, Cottu, et al. "Immune Checkpoint Inhibitors-induced Large Vessel Vasculitis: Clinical Characteristics and Management from a European Multicentre Study." Rheumatology (Oxford, England), vol. 64, no. 8, 2025, p. 4546, https://doi.org/10.1093/rheumatology/keaf172.